Schiff Andrew N's Form 4 filing
Aclaris Therapeutics, Inc. (ACRS) · filed Oct 6, 2022
- Accession no.
- 0001209191-22-053003
- Filed
- Oct 6, 2022
- Trade date
- Oct 4-6, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $749.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schiff Andrew NCIK 0001172252 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2022 | Common Stock | SSaleDisposed | −7,700 | $16.01 | −$123,277 | 626,755 | Indirect | |
| Oct 6, 2022 | Common Stock | SSaleDisposed | −37,839 | $16.54 | −$625,857.06 | 588,916 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.